Breakthrough T1D’s first-ever Clinical & Research Congress (CRC 2026), focused entirely on type 1 diabetes (T1D), has come to a close! Check out all our coverage below from the exciting weekend in Philadelphia, PA, where researchers, clinicians, industry leaders, healthcare professionals (HCPs), and the T1D community united to share updates across our entire mission.
Updates from CRC 2026 Day 1
Islet cell therapy clinical trials, complications, automated insulin delivery, clinical adoption, and how we kicked off the conference.
Updates from CRC 2026 Day 2
Disease-modifying therapy clinical trials, early detection, advocacy, the lived T1D experience, and more.
Updates from CRC 2026 Day 3
Advanced screening technologies, Centers of Reference, diabetes stigma, and the pros and cons of islet cell therapies versus disease-modifying therapies.
Thanks for joining us throughout our coverage of our Clinical & Research Congress! And thank you to everyone who helped make this conference possible, including our sponsors, donors, supporters, and staff. We couldn’t do this without you.
We couldn’t be more proud of how our inaugural conference turned out, and we’re already looking forward to next year. Mark your calendars: CRC 2027 will take place in Washington, D.C., from October 15-17, 2027!
